A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease Poladian, N., et al
Leverage The Lab Learn how Abbott's strategic transformation plan provided laboratories insights and health system performance improvements
Key Insights Fatigue is a common but usually temporary side effect during the initial weeks or dose changes in GLP-1 therapy, caused largely by rapid calorie deficit, dehydration, and metabolic adjustments. Maintaining steady energy requires prioritising nutrient-dense meals rich in protein and complex carbohydrates, staying well hydrated, and managing electrolyte balance, which helps mitigate tiredness and supports overall metabolism. Gentle physical activity and good sleep hygiene are critical lifestyle adjustments that improve circulation, mood, and energy levels without overtaxing the body during the drug adaptation period. Persistent, worsening, or debilitating fatigue should prompt medical evaluation to exclude other causes, reassess medication dosing, and ensure safe continuation of GLP-1 therapy under healthcare supervision. Frequently asked questions Why do GLP-1 medications cause fatigue
In case of pregnancy or breastfeeding, it is important to seek advice from a healthcare professional before any supplementation
This reaction accelerates dramatically with temperature, roughly doubling in rate for every 10C increase
Dose may be increased in increments of 2.5 mg every 4 weeks as needed
/assets/images/provider/photos/2775905.jpeg)
